A Trial of Levodopa in Angelman Syndrome

Completed · Phase 2/Phase 3 · Has a placebo group

Conditions studied: Angelman Syndrome

In brief

This study is designed to determine whether levodopa will lead to an improvement in the development and tremor in children with Angelman syndrome (AS). It has been suggested that levodopa, a medication that is usually used to treat Parkinson disease in adults, may help children with AS in their overall development and reduce the tremor that some of them have. If levodopa is found to be beneficial for children with AS, this could lead to a new treatment for AS. Funding Source - FDA-OOPD

Key facts

Study ID
NCT01281475
Run by
Wen-Hann Tan
People needed
67
Starts
2011-01-01
Expected to finish
2015-07-01
Last updated by the study team
2020-07-15

Who can join

Age: 4 and older, up to 12. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.